Institut Catala Doncologia

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• BeiGene2 trials

Closed trials

• Completed

  A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

  NCT03783442· Phase 3· BeiGene· Source

• Completed

  A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

  NCT03412773· Phase 3· BeiGene· Source